Literature DB >> 2435369

5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain.

D L Commins, K J Axt, G Vosmer, L S Seiden.   

Abstract

Methamphetamine (MA) in high doses produces long-term toxic effects on the serotonergic system in the rat brain, including depletions of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid and reductions in 5-HT reuptake and tryptophan hydroxylase activity. In this study, the formation of 5,6-dihydroxytryptamine (5,6-DHT), a serotonergic neurotoxin, was observed in the rat hippocampus after a single 100 mg/kg injection of MA. The 5,6-DHT was detected by reverse-phase high-performance liquid chromatography with electrochemical detection in tissue samples taken 0.5-4 h after MA administration; the highest levels of 5,6-DHT (0.032 ng/mg wet tissue) were detected at 1 h. Following administration of MA, 5-HT was also depleted in the neocortex, but 5,6-DHT was not detected as frequently in this brain region as in the hippocampus. Comparisons were made between the long-term hippocampal 5-HT depletions seen either after an injection of MA or after intraventricular 5,6-DHT infusions and the levels of 5,6-DHT measured in the hippocampus shortly after each treatment. The amount of 5,6-DHT produced after MA administration appears to be adequate to cause the observed long-term 5-HT depletions. We suggest that 5,6-DHT formed from 5-HT may mediate the neurotoxic effects of MA on serotonergic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435369     DOI: 10.1016/0006-8993(87)90116-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Functional consequences following methamphetamine-induced neuronal damage.

Authors:  M J De Vito; G C Wagner
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Labelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic system.

Authors:  M Diksic
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

Review 3.  Serotonin neurotoxins--past and present.

Authors:  H G Baumgarten; L Lachenmayer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.

Authors:  J L Fitzgerald; J J Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

5.  Peroxidase-promoted oxidation and peroxidation of the serotonergic neurotoxin 5,7-dihydroxytryptamine. A new pathway for its metabolic degradation.

Authors:  D Metodiewa; H B Dunford
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

6.  A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.

Authors:  M I Colado; A R Green
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

7.  Preliminary evidence for methamphetamine-induced behavioral and ocular effects in rat offspring following exposure during early organogenesis.

Authors:  K D Acuff-Smith; M George; S A Lorens; C V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

Authors:  J E Malberg; L S Seiden
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

Review 9.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors:  A R Green; A J Cross; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

10.  Dorsal and medial raphe nuclei participate differentially in reproductive functions of the male rat.

Authors:  María E Ayala; Diana E Velázquez; Juan L Mendoza; Juana Monroy; Roberto Domínguez; Mario Cárdenas; Andrés Aragón
Journal:  Reprod Biol Endocrinol       Date:  2015-12-08       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.